Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

United States Antimony (UAMY) Capital Expenditures (2016 - 2025)

United States Antimony's Capital Expenditures history spans 15 years, with the latest figure at $11.7 million for Q4 2025.

On a quarterly basis, Capital Expenditures rose 5556.43% to $11.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $26.3 million, a 6002.45% increase, with the full-year FY2025 number at $27.8 million, up 6358.14% from a year prior.
Capital Expenditures hit $11.7 million in Q4 2025 for United States Antimony, up from $8.7 million in the prior quarter.
Over the last five years, Capital Expenditures for UAMY hit a ceiling of $11.7 million in Q4 2025 and a floor of $23298.0 in Q1 2021.
Historically, Capital Expenditures has averaged $1.5 million across 5 years, with a median of $200998.0 in 2022.
Biggest five-year swings in Capital Expenditures: plummeted 89.48% in 2024 and later skyrocketed 11892.72% in 2025.
Tracing UAMY's Capital Expenditures over 5 years: stood at $31649.0 in 2021, then surged by 3483.66% to $1.1 million in 2022, then crashed by 83.14% to $191274.0 in 2023, then rose by 8.5% to $207538.0 in 2024, then soared by 5556.43% to $11.7 million in 2025.
Business Quant data shows Capital Expenditures for UAMY at $11.7 million in Q4 2025, $8.7 million in Q3 2025, and $5.0 million in Q2 2025.